1. Home
  2. HFBL vs ATNM Comparison

HFBL vs ATNM Comparison

Compare HFBL & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Home Federal Bancorp Inc. of Louisiana

HFBL

Home Federal Bancorp Inc. of Louisiana

HOLD

Current Price

$19.57

Market Cap

41.6M

Sector

Finance

ML Signal

HOLD

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.45

Market Cap

36.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HFBL
ATNM
Founded
1924
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.6M
36.8M
IPO Year
2010
2013

Fundamental Metrics

Financial Performance
Metric
HFBL
ATNM
Price
$19.57
$1.45
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
2.0K
174.6K
Earning Date
04-27-2026
05-08-2026
Dividend Yield
2.81%
N/A
EPS Growth
7.69
14.17
EPS
1.07
N/A
Revenue
$1,303,000.00
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.99
N/A
Revenue Growth
17.49
11.11
52 Week Low
$12.32
$0.95
52 Week High
$20.00
$1.95

Technical Indicators

Market Signals
Indicator
HFBL
ATNM
Relative Strength Index (RSI) 68.42 74.17
Support Level $15.77 $1.39
Resistance Level $20.00 $1.57
Average True Range (ATR) 0.19 0.09
MACD 0.24 0.04
Stochastic Oscillator 100.00 91.20

Price Performance

Historical Comparison
HFBL
ATNM

About HFBL Home Federal Bancorp Inc. of Louisiana

Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: